• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

Professional Introduction to N-(furan-2-yl)methylcyclopropanamine (CAS No. 831203-37-3)

N-(furan-2-yl)methylcyclopropanamine) is a significant compound in the realm of pharmaceutical chemistry, characterized by its unique structural and functional properties. This compound, identified by the CAS number 831203-37-3, has garnered considerable attention in recent years due to its potential applications in medicinal chemistry and drug development. The molecular structure of N-(furan-2-yl)methylcyclopropanamine), featuring a furan ring and a cyclopropane moiety, contributes to its distinctive chemical behavior and reactivity, making it a valuable candidate for further exploration.

The furan moiety in N-(furan-2-yl)methylcyclopropanamine) is a key feature that influences its pharmacological properties. Furan derivatives are well-documented for their diverse biological activities, including antimicrobial, anti-inflammatory, and anticancer effects. The presence of the cyclopropane ring adds another layer of complexity, as cyclopropanes are known for their stability and ability to engage in specific interactions with biological targets. This combination of structural elements makes N-(furan-2-yl)methylcyclopropanamine) a promising candidate for the development of novel therapeutic agents.

In recent years, there has been a surge in research focused on identifying new scaffolds for drug discovery. The unique structural features of N-(furan-2-yl)methylcyclopropanamine) have positioned it as a subject of interest for medicinal chemists seeking innovative molecules. Studies have demonstrated that the compound can serve as a versatile building block for the synthesis of more complex derivatives with enhanced pharmacological profiles. For instance, modifications to the furan or cyclopropane moieties can lead to compounds with improved solubility, bioavailability, and target specificity.

The potential applications of N-(furan-2-yl)methylcyclopropanamine) extend beyond traditional pharmaceuticals. Researchers are exploring its utility in agrochemicals and material science, where its structural properties could contribute to the development of novel agrochemical formulations or advanced materials. The compound's ability to interact with various biological targets makes it a valuable tool for studying molecular recognition processes and designing new chemical entities.

One of the most exciting aspects of N-(furan-2-yl)methylcyclopropanamine) is its role in the development of next-generation drugs. Current research indicates that this compound has the potential to be incorporated into drug candidates targeting complex diseases such as cancer, neurodegenerative disorders, and infectious diseases. The structural motifs present in N-(furan-2-yl)methylcyclopropanamine) allow it to mimic natural bioactive molecules and disrupt disease pathways effectively. This capability is particularly important in the context of drug resistance, where novel molecular entities are needed to overcome existing therapeutic challenges.

The synthesis of N-(furan-2-yl)methylcyclopropanamine) presents both challenges and opportunities for synthetic chemists. The integration of the furan and cyclopropane moieties requires careful consideration to ensure optimal yield and purity. Advances in synthetic methodologies have enabled more efficient routes to this compound, paving the way for large-scale production and further investigation. Techniques such as transition metal-catalyzed reactions and organometallic chemistry have been particularly useful in constructing the desired molecular framework.

The pharmacokinetic properties of N-(furan-2-yl)methylcyclopropanamine) are another area of active research. Understanding how this compound is absorbed, distributed, metabolized, and excreted (ADME) is crucial for optimizing its therapeutic potential. Preclinical studies have begun to unravel these processes, providing insights into how N-(furan-2-yl)methylcyclopropanamine) behaves within biological systems. These studies are essential for guiding future clinical trials and ensuring that the compound reaches its intended target population effectively.

In conclusion, N-(furan-2-yl)methylcyclopropanamine (CAS No. 831203-37-3) strong>) represents a fascinating compound with significant potential in pharmaceutical research. Its unique structural features, combined with its diverse biological activities, make it a valuable asset in the quest for new therapeutic agents. As research continues to uncover new applications and synthetic strategies for this molecule, its importance in drug development is likely to grow even further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)